Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 14, Issue 4

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Study

World J Hepatol. Apr 27, 2022; 14(4): 729-743
Published online Apr 27, 2022. doi: 10.4254/wjh.v14.i4.729

Full Size Figure Download Figure

Figure 1 Structure of baicalin.

Citation: Ganguly R, Kumar R, Pandey AK. Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation. World J Hepatol 2022; 14(4): 729-743
URL: https://www.wjgnet.com/1948-5182/full/v14/i4/729.htm
DOI: https://dx.doi.org/10.4254/wjh.v14.i4.729

Ganguly R, Kumar R, Pandey AK. Baicalin provides protection against fluoxetine-induced hepatotoxicity by modulation of oxidative stress and inflammation. World J Hepatol 2022; 14(4): 729-743 [PMID: 35646277 DOI: 10.4254/wjh.v14.i4.729]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.